Literature DB >> 21266266

Antihypertensive drugs in pregnancy.

Tiina Podymow1, Phyllis August.   

Abstract

Blood pressure targets and medications that are safe differ in pregnant women compared with nonpregnant individuals. The principles of treatment for mild, moderate, and severe hypertension in pregnancy, chronic versus gestational versus preeclampsia, and women hypertensive at term versus remote from term are reviewed. The choice of antihypertensive drugs also is discussed; methyldopa, labetalol, and nifedipine, among others, appear safe for use in pregnancy, whereas angiotensin converting enzyme inhibitors and angiotensin receptor blockers should be avoided. The management of increased blood pressure in the postpartum period, and agents to use in lactation, are also discussed.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21266266     DOI: 10.1016/j.semnephrol.2010.10.007

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  16 in total

1.  Postpartum hypertension.

Authors:  Kristina Powles; Shital Gandhi
Journal:  CMAJ       Date:  2017-07-10       Impact factor: 8.262

Review 2.  Mechanisms and management of hypertension in pregnant women.

Authors:  Catherine M Brown; Vesna D Garovic
Journal:  Curr Hypertens Rep       Date:  2011-10       Impact factor: 5.369

3.  Removal of Soluble Fms-Like Tyrosine Kinase-1 by Dextran Sulfate Apheresis in Preeclampsia.

Authors:  Ravi Thadhani; Henning Hagmann; Wiebke Schaarschmidt; Bernhard Roth; Tuelay Cingoez; S Ananth Karumanchi; Julia Wenger; Kathryn J Lucchesi; Hector Tamez; Tom Lindner; Alexander Fridman; Ulrich Thome; Angela Kribs; Marco Danner; Stefanie Hamacher; Peter Mallmann; Holger Stepan; Thomas Benzing
Journal:  J Am Soc Nephrol       Date:  2015-09-24       Impact factor: 10.121

Review 4.  Treatment of preeclampsia: current approach and future perspectives.

Authors:  Ecaterina Berzan; Ross Doyle; Catherine M Brown
Journal:  Curr Hypertens Rep       Date:  2014-09       Impact factor: 5.369

Review 5.  Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia.

Authors:  Dania A Shah; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2015-04-24       Impact factor: 5.858

Review 6.  Drug treatment of hypertension in pregnancy.

Authors:  Catherine M Brown; Vesna D Garovic
Journal:  Drugs       Date:  2014-03       Impact factor: 9.546

Review 7.  Stage 1 chronic kidney disease in pregnancy.

Authors:  Tiina Podymow; Phyllis August
Journal:  Obstet Med       Date:  2012-09-17

Review 8.  Anti-hypertensive treatment in pheochromocytoma and paraganglioma: current management and therapeutic features.

Authors:  Alberto Mazza; Michela Armigliato; Maria Cristina Marzola; Laura Schiavon; Domenico Montemurro; Giorgio Vescovo; Marco Zuin; Sotirios Chondrogiannis; Roberta Ravenni; Giuseppe Opocher; Patrick M Colletti; Domenico Rubello
Journal:  Endocrine       Date:  2013-07-02       Impact factor: 3.633

Review 9.  Diabetic Nephropathy in Women With Preexisting Diabetes: From Pregnancy Planning to Breastfeeding.

Authors:  Lene Ringholm; Julie Agner Damm; Marianne Vestgaard; Peter Damm; Elisabeth R Mathiesen
Journal:  Curr Diab Rep       Date:  2016-02       Impact factor: 4.810

Review 10.  Hypertension in CKD Pregnancy: a Question of Cause and Effect (Cause or Effect? This Is the Question).

Authors:  Giorgina Barbara Piccoli; Gianfranca Cabiddu; Rossella Attini; Silvia Parisi; Federica Fassio; Valentina Loi; Martina Gerbino; Marilisa Biolcati; Antonello Pani; Tullia Todros
Journal:  Curr Hypertens Rep       Date:  2016-04       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.